![spss 16 serial spss 16 serial](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/500d35c2-aaff-4a47-a978-044aad87c841/gr1_lrg.jpg)
Master of Science, New Jersey Institute of Technology, Newark, New Jersey, the United States of America Multidrug-resistant bacteria prevention and control strategies should be adjusted in a timely manner based on the surveillance results.ĭepartment of Clinical Laboratory, the Second Affiliated Hospital of Zhejiang University, Zhejiang University, Hangzhou, Zhejiang, ChinaĬlinical Microbiology Laboratory, the Third People’s Hospital of Hangzhou, Hangzhou, Zhejiang, ChinaĬhina Australia Joint Laboratory for Animal Health Big Data Analytics, College of Animal Science and Technology, Zhejiang Agricultural and Forestry University, Hangzhou, Zhejiang, China
![spss 16 serial spss 16 serial](https://1.bp.blogspot.com/-Jhc1q_hdu9o/XgnkcJ0irQI/AAAAAAAAACQ/mUyG0pOO5D86nQ8YVDY-Q1--PWg-JeE1QCLcBGAsYHQ/s640/spss21.0-installation.jpg)
Conclusionsĭespite an overall decrease in the prevalence of drug-resistant bacteria in 2019, the rising prevalence of MRSA and CRPA still warrant much attention.
![spss 16 serial spss 16 serial](https://natutool.com/wp-content/uploads/2021/07/Tai-phan-mem-SPSS-16-full-crack-mien-phi.jpg)
The prevalence of ESBL-E and CRE decreased since 2015 but that of CRPA and MRSA increased from 2014 to 2018. The prevalence of these key pathogens was lower than that reported in the national surveillance system (China Antimicrobial Resistance Surveillance System and Infectious Diseases Surveillance of Pediatrics). The prevalence of extended spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E), carbapenem-resistant Enterobacteriaceae (CRE), carbapenem-resistant Acinetobacter baumannii, carbapenem-resistant Pseudomonas aeruginosa (CRPA), and methicillin-resistant Staphylococcus aureus (MRSA) were 40.6%, 2.3%, 14.7%, 9.0%, and 27.4%, respectively. Resultsįrom 2014 to 2019, a total of 30,163 multidrug-resistant strains were identified among 212,252 clinical isolates. Statistical analysis was performed to analyze the pattern of distribution of five key bacterial pathogens in different age groups, ward settings, and bloodstream infections. Patient data were collected from the Annual Review of Hospital Infection Resistance Survey in Zhejiang Province, 2014–2019. In Zhejiang Province, China, the trends of drug-resistance in non-adult patients from 2014 to 2019 were monitored, aiming to determine the variation patterns and epidemiological features of MDR strains. The prevalence of multidrug-resistant (MDR) bacterial infections increased substantially among inpatients under 18 years of age in recent years. Antimicrobial resistance has become a major public health threat globally.